Well it’s sad to see but the lack of any news continues to keep a lid on the shareprice.
Devoid of any semblance of optimism, we just have to hang tough for a bit longer, what does surprise me is the absence of any low ball offer to take over the company.
I’d almost be happy to see something just to confirm at least that what we have is very good IP and early trial results that are impressive given the poor health of our trial participants.
Given that the options do not mature until August 2026 the current price can only be described as ridiculous at .004c, particularly given they have been as high as .07c.
It’s easy to start doubting oneself given the hammering this Company has copped in the last 12 months, however due to the lack of any concerning announcements it is clear that time alone will reveal each of our futures.
I remain cautiously optimistic about that future regardless of the constant stream of naysayers and even the lack of optimistic posters who have clearly gone into recess due to that lack of news mentioned earlier.
Azer-cel will provide further updates in 3-6 months, in either the DLBCL or the other indication mentioned by Bradley Glover on the webinar, at least we can look forward to this.
As shareholders I believe we have a responsibility at least not to bag the company, it fair to point out areas in which the board and CEO can improve their performance, however it is very counter productive to constantly run down the company.
DYOR opinion only
(20min delay)